AVTOZMA
Live / Allowed — Publication / registration review complete (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79429480
- Mark type
- Design + words
- Filed
- 18 Jun 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Max Vern
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases
Owner
- CELLTRION, INC., KR
Prosecution history
- 18 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Jan 2026 — REFUSAL PROCESSED BY IB
- 17 Dec 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 17 Dec 2025 — REFUSAL PROCESSED BY MPU
- 07 Nov 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 06 Nov 2025 — NON-FINAL ACTION WRITTEN
- 05 Nov 2025 — ASSIGNED TO EXAMINER
- 08 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 08 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB